Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check4 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual study record content and signaling restricted access to the record. The site chrome (header and navigation) remains visible as part of the error screen.SummaryDifference26%

- Check11 days agoChange DetectedThe page's revision history was updated to include new revision metadata (e.g., Revision: v3.7.0 with September 2026 dates) and to remove older revision notes (e.g., v3.6.6) from the current change set.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a small backend/template update to the Study Details page.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the template or formatting rather than changes to the study details.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision updated from v3.6.0 to v3.6.3, indicating a small underlying update to the page. This change does not alter visible content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.